see picture

[STUDY OF CIRRHOSIS IN HEPB PTX] The graph below is from: . Mak, L. et al, Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients, World ) Gastroenterol. Mar 21, 2019; 25(11): 1398-1408. http://dx.doi.org/10.3748/wjg.v25.i11.1398 This study involved assessing the use of a biomarker (Serum M2BPGi) to measure severity of liver disease among a retrospective sample of 207 patients with chronic hepatitis B. At 10 years, 16.99% of the patients had developed cirrhosis. The graph below compares the distribution of biomarker levels between patients with or without cirrhosis at three timepoints. No cirrhosis Cirrhosis P